|
MRPS18B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.702800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.437900E-02 |
| Normal-vs-Stage2 |
9.937000E-01 |
| Normal-vs-Stage3 |
4.876600E-01 |
| Normal-vs-Stage4 |
4.262800E-01 |
| Stage1-vs-Stage2 |
4.623000E-01 |
| Stage1-vs-Stage3 |
1.531580E-01 |
| Stage1-vs-Stage4 |
6.348600E-01 |
| Stage2-vs-Stage3 |
6.442200E-01 |
| Stage2-vs-Stage4 |
4.088000E-01 |
| Stage3-vs-Stage4 |
2.146800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.552400E-01 |
| Normal-vs-AfricanAmerican |
5.909400E-01 |
| Normal-vs-Asian |
4.016800E-01 |
| Caucasian-vs-AfricanAmerican |
7.223400E-01 |
| Caucasian-vs-Asian |
1.435200E-01 |
| AfricanAmerican-vs-Asian |
3.576200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.812100E-02 |
| Normal-vs-Female |
2.306600E-01 |
| Male-vs-Female |
2.784000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.927800E-01 |
| Normal-vs-Extreme_Weight |
2.754000E-01 |
| Normal-vs-Obese |
5.668400E-01 |
| Normal-vs-Extreme_Obese |
3.460000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.901370E-01 |
| Normal_Weight-vs-Obese |
3.417200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.647770E-01 |
| Extreme_Weight-vs-Obese |
7.445600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.212800E-01 |
| Obese-vs-Extreme_Obese |
4.366600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.126400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.074600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.247400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.904600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.024400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.692400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.397400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.841800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.956800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.359200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.778060E-02 |
| Normal-VS-Type2 PRCC |
9.160200E-01 |
| Normal-VS-KIRP CIMP |
5.357200E-01 |
| Normal-VS-Unclassified PRCC |
9.871200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.985190E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.103370E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.300200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.025400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.594200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.615000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.162000E-01 |
| Normal-vs-N1 |
5.989000E-01 |
| Normal-vs-N2 |
8.549900E-02 |
| N0-vs-N1 |
8.569600E-01 |
| N0-vs-N2 |
1.170560E-01 |
| N1-vs-N2 |
1.906580E-01 |
|
|
